Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside cochlear ototoxicity

G J Matz1

  • 1Loyola University Medical Center, Maywood, Illinois.

Otolaryngologic Clinics of North America
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Aminoglycoside antibiotics can cause cochlear toxicity, affecting hearing. This review covers their pharmacokinetics, comparative toxicity, and monitoring strategies, especially in vulnerable populations like neonates and children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ototoxicity resulting from combined administration of metronidazole and gentamicin.

The American journal of otology·1999
Same author

Ototoxicity resulting from combined administration of cisplatin and gentamicin.

The Laryngoscope·1996
Same author

Quantitative study of vestibulotoxicity induced by gentamicin or cisplatin in the guinea pig.

The Laryngoscope·1996
Same author

Temporal bone histopathology of cisplatin ototoxicity.

The American journal of otology·1995
Same author

Universal screening for infant hearing impairment.

Pediatrics·1994
Same author

Facial nerve monitoring in otologic surgery: clinical indications and intraoperative technique.

The Annals of otology, rhinology, and laryngology·1990
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
Same journal

Glottic Stenosis.

Otolaryngologic clinics of North America·2026
See all related articles

Area of Science:

  • Ototoxicology
  • Pharmacology
  • Nephrology

Background:

  • Aminoglycoside antibiotics are crucial for treating severe bacterial infections.
  • Cochlear toxicity is a significant adverse effect of aminoglycoside therapy.
  • Understanding aminoglycoside toxicity is vital for patient safety and effective treatment.

Purpose of the Study:

  • To provide a comprehensive overview of aminoglycoside-induced cochlear toxicity.
  • To discuss the pharmacokinetics and comparative toxicity of various aminoglycosides.
  • To highlight monitoring strategies and histopathological findings related to aminoglycoside ototoxicity.

Main Methods:

  • Review of existing literature on aminoglycoside antibiotics and cochlear toxicity.
  • Analysis of pharmacokinetic data and comparative toxicity studies.

Related Experiment Videos

  • Examination of histopathological evidence and clinical monitoring approaches.
  • Main Results:

    • Aminoglycosides exhibit variable pharmacokinetic profiles and toxicity levels.
    • Specific aminoglycosides demonstrate differing degrees of cochlear damage.
    • Toxicity is a concern in neonates and children, requiring careful monitoring.
    • Histopathological studies reveal mechanisms of inner ear damage.

    Conclusions:

    • Aminoglycoside ototoxicity is a well-documented phenomenon.
    • Individualized dosing and therapeutic drug monitoring are essential.
    • Further research into minimizing cochlear toxicity is warranted.